Skip to main content
. 2020 May 28;106(6):1559–1568. doi: 10.3324/haematol.2020.247973

Table 5.

Univariate analyses for minimal residual disease at time point 2, considering clinically relevant variables and molecular prognostic markers.

graphic file with name 1061559.tab5.jpg